Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × taxane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Triple Negative Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Ovarian Neoplasms 5 Fallopian Tube Neoplasms 4 Stomach Neoplasms 3 Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Vaccinia 1 Uterine Cervical Neoplasms 1 Solid Tumors 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Liver Neoplasms 1 HER2-negative Breast Cancer 1 Gastric Adenocarcinoma 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Small Cell 1 Brain Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Cisplatin 158 Radiotherapy 72 Brachytherapy 67 Paclitaxel 64 Carboplatin 61 pembrolizumab 57 Bevacizumab 36 Colposcopy 28 Radiation 27 Gemcitabine 27 Topotecan 25 Surveys and Questionnaires 25 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 23 Magnetic Resonance Spectroscopy 21 human papillomavirus vaccine, L1 type 16, 18 19 Papillomavirus Vaccines 19 Nivolumab 19 Platinum 18 Blood Specimen Collection 18 Biopsy 17 Drug Therapy 16 Radiotherapy, Intensity-Modulated 15 Docetaxel 15 Cyclophosphamide 15 1,2-diaminocyclohexaneplatinum II citrate 15 atezolizumab 13 Taxes 13 Papanicolaou Test 13 Methods 13 Human Papillomavirus DNA Tests 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02624531 2021-01-07

SYSUGO-005

Sun Yat-sen University

Phase NA Unknown

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡